Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: A randomized clinical trial
- PMID: 22973366
- PMCID: PMC3434899
Comparison of the narrow band UVB versus systemic corticosteroids in the treatment of lichen planus: A randomized clinical trial
Abstract
Background: Lichen planus is recognized as an inflammatory disease of the skin with different morphologic patterns. Different treatment modalities, including topical and systemic corticosteroids, methotrexate, cyclosporine, azathioprine, topical calcineurin inhibitors, and psoralen plus UVA (PUVA), have been suggested for lichen planus. Although the efficacy of narrowband UVB (NBUVB) for treatment of lichen planus has been shown, no randomized clinical trial has compared NBUVB versus systemic corticosteroids for treatment of the disease. In the current study, we evaluated the efficacy of NBUVB versus systemic corticosteroids in the treatment of the lichen planus.
Methods: Forty-six patients with confirmed diagnosis of lichen planus were randomly selected. The subjects were randomized into two groups of 23 to be treated with either systemic corticosteroids or NBUVB. All of the selected cases had generalized lichen planus that involved at least 20% of the body area and their pruritus was resistant to antihistamine drugs. Patients in the systemic corticosteroids group were treated with prednisolon 0.3 mg/kg for 6 weeks. NBUVB was performed three times a week for 6 weeks. The maximum dose of NBUVB was 9 J/cm(2). Data regarding demographic characteristics of the patients was also collected. All collected data was analyzed using SPSS(15) and statistical tests including analysis of variance (ANOVA), chi-square, and t-test.
Results: 46 patients (23 patients in systemic steroid group and 23 patients in NBUVB group) were evaluated. There was a significant difference between the 2 groups regarding the efficacy of the treatment. According to chi-square test, NBUVB was significantly more effective than systemic steroid in treatment of generalized lichen planus (p = 0.008). According to the results, patient satisfaction was also significantly higher in the group treated with NBUVB as compared with the systemic corticosteroids (p = 0.012).
Conclusions: Overall, the results of our study and other previous studies showed that NBUVB may be regarded as an effective treatment for generalized cutaneous lichen planus. This treatment may be especially utilized when there is contraindication for systemic corticosteroids or other immunosuppressive drugs.
Keywords: Lichen Planus; Narrowband UVB; Systemic Corticosteroids.
Conflict of interest statement
Similar articles
-
Comparative study of the efficacy of azathioprine, dapsone, and NB-UVB phototherapy as steroid-sparing modalities in generalised lichen planus.Indian J Dermatol Venereol Leprol. 2025 Jan-Feb;91(1):59-64. doi: 10.25259/IJDVL_383_2023. Indian J Dermatol Venereol Leprol. 2025. PMID: 39152806
-
Narrowband UVB therapy in the treatment of lichen planus.Photodermatol Photoimmunol Photomed. 2003 Oct;19(5):265-7. doi: 10.1034/j.1600-0781.2003.00051.x. Photodermatol Photoimmunol Photomed. 2003. PMID: 14535898
-
Effectiveness of Oral Methotrexate Therapy versus Systemic Corticosteroid Therapy in Treatment of Generalised Lichen Planus.J Coll Physicians Surg Pak. 2018 Jul;28(7):505-508. doi: 10.29271/jcpsp.2018.07.505. J Coll Physicians Surg Pak. 2018. PMID: 29950252 Clinical Trial.
-
Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.JAMA Dermatol. 2019 Mar 1;155(3):335-341. doi: 10.1001/jamadermatol.2018.5204. JAMA Dermatol. 2019. PMID: 30698622 Free PMC article.
-
Management of oral lichen planus.Am J Clin Dermatol. 2000 Sep-Oct;1(5):287-306. doi: 10.2165/00128071-200001050-00004. Am J Clin Dermatol. 2000. PMID: 11702320 Review.
Cited by
-
Serum level of matrix metalloproteinase-3 in patients with oral lichen planus.Iran Red Crescent Med J. 2012 Jan;14(1):10-3. Epub 2012 Jan 1. Iran Red Crescent Med J. 2012. PMID: 22737547 Free PMC article.
-
Cutaneous manifestations of viral hepatitis.Curr Infect Dis Rep. 2015 Feb;17(2):452. doi: 10.1007/s11908-014-0452-7. Curr Infect Dis Rep. 2015. PMID: 25809574
-
Lichen Planus Initially Presenting as Poikiloderma: A Challenging Case Report.Cureus. 2025 Apr 3;17(4):e81641. doi: 10.7759/cureus.81641. eCollection 2025 Apr. Cureus. 2025. PMID: 40322368 Free PMC article.
-
An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases.Cureus. 2021 Nov 1;13(11):e19182. doi: 10.7759/cureus.19182. eCollection 2021 Nov. Cureus. 2021. PMID: 34873522 Free PMC article. Review.
-
A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy.Front Med (Lausanne). 2018 Jul 2;5:184. doi: 10.3389/fmed.2018.00184. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30013973 Free PMC article.
References
-
- Shiohara T, Kano Y. Lichen planus and lichenoid dermatoses. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. 2nd ed. New York: Mosby; 2008. p. 159.
-
- Wackernagel A, Legat FJ, Hofer A, Quehenberger F, Kerl H, Wolf P. Psoralen plus UVA vs.UVB-311 nm for the treatment of lichen planus. Photodermatol Photoimmunol Photomed. 2007;23(1):15–9. - PubMed
-
- Taneja A, Taylor CR. Narrow-band UVB for lichen planus treatment. Int J Dermatol. 2002;41(5):282–3. - PubMed
-
- Saricaoglu H, Karadogan SK, Baskan EB, Tunali S. Narrowband UVB therapy in the treatment of lichen planus. Photodermatol Photoimmunol Photomed. 2003;19(5):265–7. - PubMed
LinkOut - more resources
Full Text Sources